» Articles » PMID: 24956473

Influence of Race on Microsatellite Instability and CD8+ T Cell Infiltration in Colon Cancer

Abstract

African American patients with colorectal cancer show higher mortality than their Caucasian counterparts. Biology might play a partial role, and prior studies suggest a higher prevalence for microsatellite instability (MSI) among cancers from African Americans, albeit patients with MSI cancers have improved survival over patients with non-MSI cancers, counter to the outcome observed for African American patients. CD8+ T cell infiltration of colon cancer is postively correlated with MSI tumors, and is also related to improved outcome. Here, we utilized a 503-person, population-based colon cancer cohort comprising 45% African Americans to determine, under blinded conditions from all epidemiological data, the prevalence of MSI and associated CD8+ T cell infiltration within the cancers. Among Caucasian cancers, 14% were MSI, whereas African American cancers demonstrated 7% MSI (P = 0.009). Clinically, MSI cancers between races were similar; among microsatellite stable cancers, African American patients were younger, female, and with proximal cancers. CD8+ T cells were higher in MSI cancers (88.0 vs 30.4/hpf, P<0.0001), but was not different between races. Utilizing this population-based cohort, African American cancers show half the MSI prevalence of Caucasians without change in CD8+ T cell infiltration which may contribute towards their higher mortality from colon cancer.

Citing Articles

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer.

Fan W, Su F, Zhang Y, Zhang X, Du Y, Gao Y Biomark Res. 2024; 12(1):89.

PMID: 39183366 PMC: 11346251. DOI: 10.1186/s40364-024-00640-7.


THE JEREMIAH METZGER LECTURE: ENVIRONMENTAL INFLUENCES ON COLORECTAL CANCER.

Carethers J Trans Am Clin Climatol Assoc. 2024; 134:181-199.

PMID: 39135583 PMC: 11316861.


Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.

Lawler T, Parlato L, Andersen S Cancer Causes Control. 2023; 35(2):223-239.

PMID: 37688643 PMC: 11090693. DOI: 10.1007/s10552-023-01783-y.


Investigating miR-9 as a mediator in laryngeal cancer health disparities.

Gobin C, Inkabi S, Lattimore C, Gu T, Menefee J, Rodriguez M Front Oncol. 2023; 13:1096882.

PMID: 37081981 PMC: 10112398. DOI: 10.3389/fonc.2023.1096882.


Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.

Telisnor G, DeRemer D, Frimpong E, Agyare E, Allen J, Ricks-Santi L J Natl Med Assoc. 2023; 115(2):164-174.

PMID: 36801148 PMC: 10639003. DOI: 10.1016/j.jnma.2023.01.008.


References
1.
Tseng-Rogenski S, Chung H, Wilk M, Zhang S, Iwaizumi M, Carethers J . Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells. PLoS One. 2012; 7(11):e50616. PMC: 3511561. DOI: 10.1371/journal.pone.0050616. View

2.
Lieberman D, Holub J, Moravec M, Eisen G, Peters D, Morris C . Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008; 300(12):1417-22. PMC: 3878153. DOI: 10.1001/jama.300.12.1417. View

3.
Siegel R, DeSantis C, Jemal A . Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):104-17. DOI: 10.3322/caac.21220. View

4.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

5.
Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, Knaebel H . Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology. 2008; 134(4):988-97. DOI: 10.1053/j.gastro.2008.01.015. View